Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Oncology
Recent findings illuminate research in oncology
April 19th, 2005
Investigators in South Korea, United States and Japan have published new oncology data. Study 1: Promoter-driven apoptin expression impedes small-cell lung cancer growth. "Apoptin is derived from chicken anemia virus (CAV) and known to induce tumor specific apoptosis but not in normal cells. The aim of this study was to use increased expression of apoptin by the Myc-Max response element (MMRE) and SV40 enhancer in small-cell lung cancer (SCLC) gene therapy," investigators in South Korea report. "To investigate the possibility of the utilization of the MMRE, apoptin, and SV40 promoter/enhancer in targeted cancer gene therapy,...
Source: Cancer Weekly (2005-04-19)
|
